{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:30:28Z","timestamp":1778049028017,"version":"3.51.4"},"reference-count":57,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T00:00:00Z","timestamp":1234742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p>\n                    <jats:bold>Background and purpose:\u2002<\/jats:bold>\n                    Highly selective M\n                    <jats:sub>3<\/jats:sub>\n                    muscarinic receptor antagonists may represent a better treatment for overactive bladder syndrome, diminishing side effects. Cardiac side effects of non\u2010selective antimuscarinics have been associated with activity at M\n                    <jats:sub>2<\/jats:sub>\n                    receptors as these receptors are mainly responsible for muscarinic receptor\u2010dependent bradycardia. We have investigated a novel antimuscarinic, SVT\u201040776, highly selective for M\n                    <jats:sub>3<\/jats:sub>\n                    over M\n                    <jats:sub>2<\/jats:sub>\n                    receptors (Ki\u2003=\u20030.19\u2003nmol\u00b7L\n                    <jats:sup>\u22121<\/jats:sup>\n                    for M\n                    <jats:sub>3<\/jats:sub>\n                    receptor affinity). This study reports the functional activity of SVT\u201040776 in the bladder, relative to its activity in atria.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Experimental approach:\u2002<\/jats:bold>\n                    <jats:italic>In vitro<\/jats:italic>\n                    and\n                    <jats:italic>ex vivo<\/jats:italic>\n                    (oral dosing) inhibition of mouse detrusor and atrial contractile responses to carbachol were used to study the functional activity of SVT\u201040776. The\n                    <jats:italic>in vivo<\/jats:italic>\n                    efficacy of SVT\u201040776 was characterized by suppression of isovolumetric spontaneous bladder contractions in anaesthetized guinea pigs after intravenous administration.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Key results:\u2002<\/jats:bold>\n                    SVT\u201040776 was the most potent in inhibiting carbachol\u2010induced bladder contractions of the anti\u2010cholinergic agents tested, without affecting atrial contractions over the same range of concentrations. SVT\u201040776 exhibited the highest urinary versus cardiac selectivity (199\u2010fold). In the guinea pig\n                    <jats:italic>in vivo<\/jats:italic>\n                    model, SVT\u201040776 inhibited 25% of spontaneous bladder contractions at a very low dose (6.97\u2003\u00b5g\u00b7kg\n                    <jats:sup>\u22121<\/jats:sup>\n                    i.v), without affecting arterial blood pressure.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions and implications:\u2002<\/jats:bold>\n                    SVT\u201040776 is a potent inhibitor of M\n                    <jats:sub>3<\/jats:sub>\n                    receptor\u2010related detrusor contractile activity. The absence of effects on isolated atria preparations represents an interesting characteristic and suggests that SVT\u201040776 may lack unwanted cardiac effects; a feature especially relevant in a compound intended to treat mainly elderly patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>British Journal of Pharmacology<\/jats:italic>\n                    (2009) doi:10.1111\/j.1476\u20105381.2008.00082.x\n                  <\/jats:p>","DOI":"10.1111\/j.1476-5381.2008.00082.x","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T09:13:26Z","timestamp":1234775606000},"page":"807-817","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["<i>In vivo<\/i>\n                    and\n                    <i>in vitro<\/i>\n                    pharmacological characterization of SVT\u201040776, a novel M\n                    <sub>3<\/sub>\n                    muscarinic receptor antagonist, for the treatment of overactive bladder"],"prefix":"10.1111","volume":"156","author":[{"given":"C","family":"Salcedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Davalillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cabellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lagunas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Balsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"P\u00e9rez\u2010del\u2010Pulgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ballar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AG","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02243-4"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706780"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655902320766006"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(02)00045-3"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00622-7"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07100.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","article-title":"Antimuscarinics and the overactive detrusor \u2013 which is the main mechanism of action?","volume":"43","author":"Andersson KE","year":"2003","journal-title":"Eur Urol"},{"key":"e_1_2_7_9_1","unstructured":"BalsaD SalcedoC EnrichA DavalilloS CabellosJ PellicerTet\u2003al.(2004).SVT\u201040776: a selective competitive and reversible antagonist of the human recombinant muscarinic M3 receptor. International Continence Society 34th Annual Meeting 2004 (Abstract 260)."},{"key":"e_1_2_7_10_1","unstructured":"BalsaD SalcedoC EnrichA DavalilloS CabellosJ Fern\u00e1ndezAG(2005).Functional bladder selectivity of SVT\u201040776: a comparative study. 35th Annual Meeting of the International Continence Society. Montreal. P 284."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.063271"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00591-8"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(93)90027-B"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05454.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2680.2001.00231.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704897"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704165"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701920"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00587-6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2001.0835"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0031-6997(25)06957-1","article-title":"Muscarinic receptor subtypes and smooth muscle function","volume":"48","author":"Eglen RM","year":"1996","journal-title":"Pharmacol Rev"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.077909"},{"key":"e_1_2_7_23_1","unstructured":"FarreronsC CatenaJ Fernandez\u2010SerratA MiquelI BalsaD BonillaJIet\u2003al.(2002)Carbamates derived from arylalkylamines. PCT\/ES01\/00252 [WO 02\/00652]."},{"key":"e_1_2_7_24_1","unstructured":"Fern\u00e1ndezAG ViaynaC SalcedoC DavalilloS Sanagust\u00ednJ BalsaDet\u2003al.(2005)Bladder selectivity of SVT\u201040776: a pharmacokinetic\/pharmacodynamic (PK\/PD) analysis based on preclinical and clinical studies. International Continence Society 35th Annual Meeting 2005."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704781"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00214-3"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67039-3"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90149-A"},{"key":"e_1_2_7_29_1","first-page":"CD005429","article-title":"Which anticholinergic drug for overactive bladder symptoms in adults","volume":"20","author":"Hay\u2010Smith J","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00581-5"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701048"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050507"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7394.841"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.75.5.813"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-8673.1995.tb00344.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4_MeetingAbstracts.257S-c"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00044-7"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703551"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb15065.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.17.9579"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-24-10627.2002"},{"key":"e_1_2_7_42_1","first-page":"CD003781","article-title":"Anticholinergic drugs versus placebo for overactive bladder syndrome in adults","volume":"4","author":"Nabi G","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_43_1","first-page":"A124","article-title":"The effects of darifenacin and tolterodine on Heart Rate (HR) in patients with overactive bladder","volume":"25","author":"Olshansky B","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_7_44_1","doi-asserted-by":"crossref","unstructured":"OlshanskyB EbingerU EgermarkM LuthraA RekedacA BrumJ(2008).Antimuscarinics and heart rate: results from a randomized double\u2010blind placebo\u2010controlled 3 way crossover study in subjects over age 50. ICI 2008 July 5\u20138 Paris Abst 32","DOI":"10.3834\/uij.1939-4810.2008.06.32"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00391.2003"},{"key":"e_1_2_7_46_1","first-page":"88S","article-title":"Impact of darifenacin compared with tolterodine on incontinence episodes in patients with overactive bladder","volume":"105","author":"Romanzi LJ","year":"2005","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_47_1","first-page":"382","article-title":"SVT\u201040776, a new selective M3 muscarinic antagonist: human receptor binding profile and bladder effects in the guinea\u2010pig","volume":"22","author":"Salcedo C","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.063735"},{"key":"e_1_2_7_49_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0026-895X(24)12174-8","article-title":"Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts","volume":"55","author":"Shi H","year":"1999","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_50_1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)35366-2","article-title":"M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro","volume":"292","author":"Stengel PW","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08438.x"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00221-6"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.103093"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.06.088"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.5.1029"},{"key":"e_1_2_7_56_1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-3565(25)09628-4","article-title":"Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins","volume":"273","author":"Wang P","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01784-3"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.08.028"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2008.00082.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2008.00082.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:59:01Z","timestamp":1738936741000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2008.00082.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1476-5381.2008.00082.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00082.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1158547.618731","asserted-by":"object"}]},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2009-03-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}